---
title: "Ampron: Inquiry for transfer pricing at 70.89 yuan/share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236769220.md"
description: "Ampron announced that based on the inquiry subscription situation on April 21, 2025, the price for this non-public transfer is set at 70.89 yuan per share. Participating institutional investors submitted 7 valid bid documents, with a total of 1.37 million shares subscribed and a valid subscription multiple of 1.39 times. The preliminary determined transferees are 7 institutional investors, with a total number of shares to be transferred amounting to 984,100 shares"
datetime: "2025-04-21T10:50:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236769220.md)
  - [en](https://longbridge.com/en/news/236769220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236769220.md)
---

# Ampron: Inquiry for transfer pricing at 70.89 yuan/share

Ampron announced that, based on the inquiry subscription situation on April 21, 2025, the preliminary inquiry transfer price is set at 70.89 yuan per share. This inquiry transfer is a non-public transfer and will not be conducted through centralized bidding trading methods. A total of 7 valid bid sheets were submitted by institutional investors participating in this inquiry transfer, covering professional institutions such as fund management companies, securities companies, and private fund managers, with a total valid subscription of 1.37 million shares and a valid subscription multiple of 1.39 times. The preliminary determined transferees are 7 institutional investors, with a total number of shares to be transferred amounting to 984,100 shares

### Related Stocks

- [301413.CN](https://longbridge.com/en/quote/301413.CN.md)
- [399975.CN](https://longbridge.com/en/quote/399975.CN.md)

## Related News & Research

- [ANALYSIS-Sustainable fund launches stutter amid industry caution](https://longbridge.com/en/news/294769932.md)
- [R&D 100 Awards Honor 4 NLR Innovations](https://longbridge.com/en/news/295289278.md)
- [Toralgen Demonstrates Oral Delivery Across Multiple Diabesity Peptide Classes, Advancing the Potential of Oral Biologics](https://longbridge.com/en/news/294857699.md)
- [Cribl launches AI Observability app with new security capabilities](https://longbridge.com/en/news/294718323.md)
- [TSRL Receives Second-Year NIH Notice of Award to Advance Microneedle Patch for Overactive Bladder Therapy](https://longbridge.com/en/news/294829522.md)